Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

ImmunoCellular Therapeutics Ltd IMUC

Sector: Healthcare | Sub-Sector: Biotechnology

ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
Price: $0.712 | Change: $-0.003 | %Change: -0.45%
Volume: 156,395 | Day High/Low: 0.724/0.702 | 52 Week High/Low: 4.00/0.65
View modes: 
0 stars

What was the maket expecting?

I did not know how the market would take the news but never expected it to go down. Picked up some at the open but should have waited but I am a shareholder again.  rate and reply
0 stars

Good news!

I had sold all my shares, but may pick up a new position. They have a subgroup that may be good enough for approval. Since HLA2 is only in about half the patients and Merthylated is also only in less...read more
0 stars

Major problem


...read more
0 stars

RE:Ugly!

As a side note it seems that Dr. Yu did know something, how much I don't know but his selling was not a coincidence in my opinion.  rate and reply
0 stars

Ugly!

What can I say not much to hang onto. This was my favorite stock of all my stocks. This poor trial result will also affect my NWBO position because they had a similar result in phase one even with a...read more
0 stars

NWBO announced events!

NWBO announced the 66 events that trigger an analysis from the DMC, results in 6 to 8 weeks. This seems normal to me I strongly feel that IMUC should announce the event when it happens it may already...read more
0 stars

Methylated subjects MGMT

Their has been a debate as what effect MGMT gene has on prognosis. I have been concerned that some of the effect we have had in phase one was because we had a higher percentage of MGMT patients than...read more
0 stars

Size of the market really does not matter!

Even if it was only ten percent of the market an approval would mean the platform works and you could expect a multiple higher in stock price. If we get a 10 month survival advantage which I expect we...read more
1 star

RE:RE:RE:Cedar Sinai

Have to correct my earlier post..it seems new cases of the tumors in question run about 2,300 and, as with the trial selection, it would presumably be the case that not of all these would 'qualify...read more
0 stars

Group movement

Along with NWBO moving last week we have the strong chart of GALE in the last month sector is hot and news has an enhanced effect. I expect the group to continue to perform well.  rate and reply
0 stars

RE:RE:RE:Cedar Sinai

I have a personal bone to pick with the FDA  and get a little peeved when people expect them to see the obvious. If you show them the results they would come up with a dozen reasons why it might be an...read more
0 stars

RE:RE:Cedar Sinai

I am not under any weird impressions and perhaps you'd care to phrase your point another way in the future, but all elements of that study are statistically significant and 8 out of 16 is still 8 out...read more
0 stars

RE:Cedar Sinai

You seem to be under some weird impression  that the FDA is a resonable organization.  In fact I will predict that unless we get at least a  six months  OS against the control in phase two we will not...read more
0 stars

Cedar Sinai

By 'pushing"I presume you mean that update they just sent around...makes me wonder why this Ph3 isn't stopped and 107 fast-tracked. Outstanding results. Wonder if they can analyse differences in the...read more
0 stars

Nice Move

First they move NWBO now even though I love the stock I think the traders are pushing this sector right  . Even though I tryed to trade NWBO I will not try that with IMUC. It seems that Cedar Sinai is...read more
5 stars

RE:Company statement!

It has become clear to me that the company will have prior knowledge of the 64th event but because they do not consider it material will not tell the shareholders. This is BS in my opinion, I guess...read more
0 stars

Company statement!

The one thing that really bothers me is the statement that it takes three to four months to analyze the data after the 64th event. After following biotech for fifteen years this seems very excessive...read more
0 stars

Treading water!

Stock just seems to be in a trading range not much to say.  Yahoo seems to be dominated by bashers which does not bother me except the one that says we should have kept Singh as president. I was livid...read more
0 stars

Q2 details

The decrease in cash usage was driven by a reduction in patient related expenses in the phase II trial of ICT-107 Read here  rate and reply
0 stars

FDA KILLS

The stock acted very well yesterday, let's see what happens today. Yesterday the chart looked amazing with an obvious big buyer slowly accumulating but it's only one day and I don't see a short term...read more

Private Equity

FOUNDING MEMBER OFFER



 
Register Now To Become A Founding Member

Private Equity: Find out why it returned 16% p.a. for 10 years.


Click here to watch the video